The Global Newborn Screening Market is forecasted to reach USD 2.27 Billion by 2027, according to a new report by Emergen Research. Newborn screening tests in infants check for developmental, metabolic, and genetic abnormalities. Newborn screening includes more than 30 illnesses and conditions. Additionally, various governmental and non-profit agencies are primarily focusing on providing quality fetal and maternal care. Besides, the industry is expected to experience a boost in demand due to the involvement of federal bodies involved in coordinating awareness and quality control programs to imbibe confidence and low the number of deaths caused by negligence and non-screening. New treatments such as enzyme replacement therapy, hematopoietic stem cell transplant, gene therapy, and novel therapeutic drugs have allowed the inclusion of autoimmune disorders as possible candidates in NBS programs.
The advent of modern and innovative screening technologies, and subsequent drug approvals, is expected to have a positive effect on the Newborn screening industry. Also, the growing prevalence of congenital cardiac diseases and genetic disorders among New-borns is expected to propel the Newborn screening market. While the lack of parental awareness about neonatal screening, limited availability of qualified practitioners, and lack of accuracy in some of the tests are the key factors that can hinder the development of the Newborn screening market.
The report is refurbished with the impact of the COVID-19 pandemic on the global Newborn Screening market. The pandemic and subsequent social restrictions have dynamically changed the market and impacted the economic scenario of the market through disruptions in the supply chains, financial difficulties, and changes in the demands and trends of the industry. Moreover, a shift in consumer behavior has also affected the Newborn Screening industry. The report provides an in-depth impact analysis of the pandemic on the market to better understand the latest changes in the market and gain a futuristic outlook on a post-COVID-19 scenario.
To get a sample copy of the latest report, visit @ https://www.emergenresearch.com/request-sample/
Key Players Profiled in the Report:
Bio-Rad Laboratories Inc., Agilent Technologies Inc., Trivitron Healthcare, Natus Medical Inc., PerkinElmer Inc., AB Sciex LLC, Covidien Plc, Masimo Corp., GE Healthcare, and Waters Corp., among others.
Global Newborn Screening Market Segmentation:
The market is broadly categorized on the basis of product types offered in the market, region, broad application spectrum, and the leading manufacturers/companies.
For the purpose of this report, Emergen Research has segmented the global Newborn Screening Market on the basis of Technology, Product, Application, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assay
DNA Assay
Electrophoresis
Others
Product Outlook (Revenue, USD Billion; 2017-2027)
Instruments
Reagents
Assay Kits
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Dry Blood Spot Test
Critical Congenital Heart Disease (CCHD)
Hearing Screen
Others
To purchase the report, visit @ https://www.emergenresearch.com/select-license/4
Key Features of the Global Newborn Screening Market:
The report offers a deep insight into the market with expert data insights from the industry experts and analysts
Dedicated focus on market growth and restraining factors
Thorough analysis of the market segments includes product types, application spectrum, technology, end-user, and other key segments
SWOT and Porter’s Five Forces analysis along with feasibility analysis and venture return analysis
Current and emerging market trends and growth prospects
A detailed market forecast spanning 8 years from 2020 to 2027
Some Key Highlights from the Report
Based on the technology, electrophoresis generated a revenue of USD 0.15 billion in 2019 and is predicted to rise with a CAGR of 11.1% in the forecast period owing to the increasing demand and new detection techniques that assist in recognition of amino acids, carnitine conjugates, and other compounds.
The assay kits are expected to grow with a CAGR of 10.4% in the forecasted period, attributable to its wide variety of classes such as enzymatic assay kits, DNA assay kits, immunoassay kits, and others of which immunoassay is a process-oriented used in the screening.
The dry blood spot test application is the major contributor to the Newborn Screening Market. The dry blood spot test application of the North America region is the major shareholder of the market and held around 43.1% of the market in the year 2019.
North America dominated the market with a share of 34.7% in 2019 due to its adoption of cost-effective and innovative procedures.
Regional Segmentation:
The report offers a comprehensive analysis of the current growth opportunities for various regions of the prepreg market, calculating their revenue share over the forecast timeline. Furthermore, the report analyzes the year-on-year growth rate of these regions over the forecast duration. The leading geographic regions encompassed in the report include:
North Americ
Europe
Asia Pacific
Latin America
Middle East & Africa
In conclusion, the report provides a qualitative and quantitative analysis of the Global Newborn Screening market, including the global and regional analysis of the market. The study covers critical information and factual data about the Newborn Screening industry, along with an in-depth statistical analysis of the market drivers, limitations, growth prospects, opportunities, and threats. On the basis of the current market scope, the report provides an extensive analysis of how the Newborn Screening market is expected to fare in the forecast timeline. The report utilizes advanced analytical tools to offer an estimation of the outlook of the global state of the Newborn Screening industry.
To receive a customized copy of the report, click on the link here @ https://www.emergenresearch.com/request-for-customization/4
Thank you for reading our report. For further inquiries about the customization of the report or to know more details about it, please connect with us. Our team will make sure your report is designed as per your needs.
Take a Look at our Related Reports:
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting
Read Press Release@ https://www.emergenresearch.com/press-release/global-newborn-screening-market